Cardiac Assist Devices – Market Insights – United States

The US cardiac assist device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by expanded use of cardiac assist devices in a wider range of patients.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for cardiac assist devices in the US from 2019 through 2032.

Recalls and various market developments have been pivotal factors shaping the cardiac assist device market. 

Which device segments have been most strongly affected?

Which companies have lost share or have entirely withdrawn from device segments?

In what manner have mergers and acquisitions influenced the market dynamics?

Which segments, previously expected to undergo growth, have been hindered by recent market developments?

Innovative novel devices will play a major role in changing the landscape of the cardiac assist device market.

Which device segments are expected to see product innovations?

Which key design features are competitors emphasizing?

How will procedure volumes be affected by emerging products?

Clinical trials have a strong impact on the cardiac assist device market. 

Which competitors have early feasibility studies underway?

Which additional indications are expected to receive approval based on positive trial results?

Which trials have experienced delays, and how has this impacted the device markets and associated forecasts? 

Which competitors are benefiting the most from accumulating clinical evidence? 

Table of contents